These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1183097)

  • 21. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of free non-protein bound clofibrinic acid after single dosing to patients with impaired renal function of various degrees--a multicenter study.
    Merk W; Graben N; Hartmann H; Nikolaus C; Schlierf G; Schwandt P
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):59-62. PubMed ID: 3557732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of hydroxy-DL-proline-2-(14)C in the investigation of hydroxyproline metabolism in normal subjects and in patients with renal insufficiency.
    Hart W; van den Hamer CJ; van der Sluys Veer J
    Clin Nephrol; 1976 Sep; 6(3):379-87. PubMed ID: 991465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uremic osteodystrophy. Critical evaluation of the radiologic and humoral indices of bone resorption].
    Galmozzi C; Casati S; Rivolta E; De Vecchi A; Imbasciati E; Cecchettin M; Brancaccio D; Ponticelli C
    Minerva Nefrol; 1979; 26(3):405-8. PubMed ID: 262283
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency.
    Duursma SA; Visser WJ; Mees EJ; Njio L
    Calcif Tissue Res; 1974; 16(2):129-38. PubMed ID: 4447892
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA
    Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of parathyroid hormone on bone resorption in uremic patients.
    Arata RO; Campos C; Mautalen CA
    Medicina (B Aires); 1976; 36(2):113-20. PubMed ID: 933833
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute responsiveness to calcitonin in chronic renal failure.
    Cochran M; Hillyard CJ; Dew GJ; Martin TJ
    Br Med J; 1976 Aug; 2(6032):396-8. PubMed ID: 947443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A; McChesney R; Irvine RO; Dixon SR
    N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
    [No Abstract]   [Full Text] [Related]  

  • 32. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
    Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
    Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hydroxyproline fractions in blood (author's transl)].
    Struck H; Nagelschmidt M
    J Clin Chem Clin Biochem; 1977 Nov; 15(11):625-8. PubMed ID: 925627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocalcaemia and bone disease in renal failure.
    Cochran M; Bulusu L; Horsman A; Stasiak L; Nordin BE
    Nephron; 1973; 10(2):113-40. PubMed ID: 4710977
    [No Abstract]   [Full Text] [Related]  

  • 35. The elimination of free, peptide-bound and protein-bound hydroxyproline into dialysate during peritoneal dialysis in patients with renal failure.
    Kowalewski J; Tomaszewski J; Hanzlik J; Zawislak H; Zbikowska A
    Clin Chim Acta; 1971 Aug; 34(1):123-6. PubMed ID: 5118724
    [No Abstract]   [Full Text] [Related]  

  • 36. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
    Ionova D; Zlatarska S; Kirjakov Z
    Nephrol Dial Transplant; 1995; 10(9):1782. PubMed ID: 8559512
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum hydroxyproline values in patients with chronic renal insufficiency (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Pribylincová V; Borosová E; Reznícek J
    Bratisl Lek Listy; 1979 Jun; 71(6):633-40. PubMed ID: 455098
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbamylated plasma protein in renal failure.
    Oimomi M; Nishimoto S; Matsumoto S; Hatanaka H; Ishikawa K; Kawasaki T; Yoshimura Y; Baba S
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):269-71. PubMed ID: 3723861
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Plasma biochemistry in haemodialysed patients.
    Bishop MC
    Lancet; 1973 Dec; 2(7841):1328-9. PubMed ID: 4127674
    [No Abstract]   [Full Text] [Related]  

  • 40. Free and protein-bound hydroxyproline in human serum.
    Amma MK; Tandon HK; Sharma SK
    Indian J Med Res; 1971 Aug; 59(8):1312-7. PubMed ID: 4332062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.